ConductScience.org, home

Paper8306366

Relationship between soluble tumor necrosis factor (TNF) receptors and TNF alpha during immunotherapy with interleukin-2 and/or interferon alpha.

Landmann R and 7 others. Cancer Immunol Immunother, 1994. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. Relationship between soluble tumor necrosis factor (TNF) receptors and TNF alpha during immunotherapy with interleukin-2 and/or interferon alpha. Papers, record 8306366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8306366

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Relationship between soluble tumor necrosis factor (TNF) receptors and TNF alpha during immunotherapy with interleukin-2 and/or interferon alpha.
PubMed
Journal
Cancer Immunol Immunother
PubMed
Year
1994
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
0.49
iCite
Revised in PubMed
2024-04-26
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Landmann RR
2Keilholz UU
3Scheibenbogen CC
4Brockhaus MM
5Gallati HH
6Denz HH
7Bargetzi MM
8Ludwig CC

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Interferon-alphaMajor topic
Receptors, Tumor Necrosis FactorMajor topic
Tumor Necrosis Factor-alphaMajor topic
Adult
Aged
Carcinoma
Carcinoma, Renal Cell
Female
Humans
Immunotherapy
Interleukin-2
Male
Melanoma
Middle Aged
Recombinant Proteins
Skin Neoplasms
Solubility
Thyroid Neoplasms

Source PubMed

Download CSV of topics

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13040886Effect of tumor necrosis factor alpha on mitogen-activated human B cells.J Exp Med1987https://conductscience.org/library/papers/3040886PubMed
23147899Monocytic production and plasma bioactivities of interleukin-1 and tumour necrosis factor in human cancer.Eur J Clin Invest1988https://conductscience.org/library/papers/3147899PubMed
31655258Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients.Cancer Res1991https://conductscience.org/library/papers/1655258PubMed
41544123Regional administration of lymphokine-activated killer cells can be superior to intravenous application.Cancer1992https://conductscience.org/library/papers/1544123PubMed
53285747NIH conference. New approaches to the immunotherapy of cancer using interleukin-2.Ann Intern Med1988https://conductscience.org/library/papers/3285747PubMed
62661690Induction of endogenous cytokine-mRNA in circulating peripheral blood mononuclear cells by IL-2 administration to cancer patients.J Immunol1989https://conductscience.org/library/papers/2661690PubMed
73928750Effect of interleukin 2, interferon-gamma, and mitogens on the production of tumor necrosis factors alpha and beta.J Immunol1985https://conductscience.org/library/papers/3928750PubMed
81322942Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia.J Clin Invest1992https://conductscience.org/library/papers/1322942PubMed
91321854Both tumor necrosis factor receptor types mediate proliferative signals in human mononuclear cell activation.J Immunol1992https://conductscience.org/library/papers/1321854PubMed
101649557Tumor necrosis factor receptors in lymphoid tissues and lymphomas. Source and site of action of tumor necrosis factor alpha.Am J Pathol1991https://conductscience.org/library/papers/1649557PubMed
118443808A direct comparison of immunological and clinical effects of interleukin 2 with and without interferon-alpha in humans.Cancer Res1993https://conductscience.org/library/papers/8443808PubMed
122506138Differential modulation by tumor necrosis factor and immune interferon of HLA class-II antigens expressed by melanoma cells.Int J Cancer1989https://conductscience.org/library/papers/2506138PubMed
133265420Induction of circulating tumor necrosis factor (TNF alpha) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients.J Clin Immunol1988https://conductscience.org/library/papers/3265420PubMed
142160731A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins.Science1990https://conductscience.org/library/papers/2160731PubMed
151997108Clinical and immune modulatory effects of alternative weekly interleukin-2 and interferon alfa-2a in patients with advanced renal cell carcinoma and melanoma.Br J Cancer1991https://conductscience.org/library/papers/1997108PubMed
161707931Involvement of the 55- and 75-kDa tumor necrosis factor receptors in the generation of lymphokine-activated killer cell activity and proliferation of natural killer cells.J Immunol1991https://conductscience.org/library/papers/1707931PubMed
172457708Human natural cytotoxic activity mediated by tumor necrosis factor: regulation by interleukin-2.J Natl Cancer Inst1988https://conductscience.org/library/papers/2457708PubMed
188319195Interferon-alpha and interleukin-2 in the treatment of metastatic melanoma. Comparison of two phase II trials.Cancer1993https://conductscience.org/library/papers/8319195PubMed
191969983Spontaneous production of tumour necrosis factor alpha and interleukin-1 beta during interferon-alpha treatment of chronic HBV infection.Lancet1990https://conductscience.org/library/papers/1969983PubMed
203798026Detection of tumour necrosis factor-like cytotoxicity in serum from patients with septicaemia but not from untreated cancer patients.Scand J Immunol1986https://conductscience.org/library/papers/3798026PubMed

See all 37 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
22451470Total and abdominal adiposity are associated with inflammation in older adults using a factor analysis approach.J Gerontol A Biol Sci Med Sci2012https://conductscience.org/library/papers/22451470PubMed
21632552Prediagnostic serum levels of cytokines and other immune markers and risk of non-hodgkin lymphoma.Cancer Res2011https://conductscience.org/library/papers/21632552PubMed
9708191Multifaceted inhibition of anti-tumour immune mechanisms by soluble tumour necrosis factor receptor type I.Immunology1998https://conductscience.org/library/papers/9708191PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IFNA13439PubTator's text mininghttps://conductscience.org/library/genes/3439NCBI Gene
IL23558PubTator's text mininghttps://conductscience.org/library/genes/3558NCBI Gene
IL2RA3559PubTator's text mininghttps://conductscience.org/library/genes/3559NCBI Gene
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124NCBI Gene
TNFRSF1B7133PubTator's text mininghttps://conductscience.org/library/genes/7133NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8306366

GET https://conductscience.org/api/papers/v1/8306366/references?page=2